Keywords: YUD; Y-type urethra duplication; VCUG; voiding cysto-urethrogram; IVU; intravenous urography; PADUA; progressive augmentation by dilating urethra anterior; LUTO; lower urinary tract obstruction; VUR; vesicoureteral reflux; UTIs; urinary tract infections;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial
Keywords: prostatic hyperplasia; phosphodiesterase inhibitors; urodynamics; urinary bladder neck obstruction; BOOI; bladder outlet obstruction index; BPH; benign prostatic hyperplasia; BPH-LUTS; LUTS secondary to clinical BPH; ED; erectile dysfunction; I-PSS; Inter
Can Staccato and Interrupted/Fractionated Uroflow Patterns Alone Correctly Identify the Underlying Lower Urinary Tract Condition?
Keywords: lower urinary tract symptoms; urination; urination disorders; urologic diseases; DU; detrusor underactivity; DV; dysfunctional voiding; EMG; electromyography; ICCS; International Children's Continence Society; ICS; International Continence Society; IDOD;
Urinating in the Standing Position: A Feasible Alternative for Elderly Women With Knee Osteoarthritis
Keywords: urination; female; osteoarthritis; knee; urodynamics; toilet facilities; AUA; American Urological Association; OA; osteoarthritis; PVR; post-void residual urine; Qave; average flow rate; Qmax; maximal flow rate; QOL; quality of life; VV; voided volume;
Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial
Keywords: prostatic hyperplasia; phosphodiesterase inhibitors; urodynamics; urinary bladder neck obstruction; BOOI; bladder outlet obstruction index; BPH; benign prostatic hyperplasia; BPH-LUTS; LUTS secondary to clinical BPH; ED; erectile dysfunction; I-PSS; Inter